Methods Of Treating Plantar Fibromatosis
Summary
The USPTO published patent application US20260091093A1 disclosing methods of treating plantar fibromatosis. The application (No. 19288249) was filed August 1, 2025, and names five inventors including James P. Tursi and Jeffrey David Lehrman. The invention relates to therapeutic methods using compositions classified under A61K 38/4886.
What changed
The USPTO published a patent application disclosing methods of treating plantar fibromatosis in a subject or population of subjects. The application (US20260091093A1, Application No. 19288249) was filed on August 1, 2025, and published April 2, 2026. Five inventors are named: James P. Tursi, Luis A. Ortega, Qinfang Xiang, Saji Vijayan, and Jeffrey David Lehrman. The CPC classifications indicate the invention involves biological compositions (A61K 38/4886) for therapeutic use.
Pharmaceutical companies and healthcare providers interested in plantar fibromatosis treatments should review the application to assess potential licensing opportunities or competitive landscape implications. There are no compliance deadlines or regulatory requirements imposed by this publication. Parties should monitor the prosecution of this application through the USPTO to track any issued patents that may affect freedom-to-operate analyses.
Archived snapshot
Apr 2, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Methods Of Treating Plantar Fibromatosis
Application US20260091093A1 Kind: A1 Apr 02, 2026
Inventors
James P. Tursi, Luis A. Ortega, Qinfang Xiang, Saji VIJAYAN, Jeffrey David Lehrman
Abstract
Disclosed herein are methods of treating plantar fibromatosis in a subject or a population of subjects.
CPC Classifications
A61K 38/4886 A61P 35/00 C12Y 304/24003
Filing Date
2025-08-01
Application No.
19288249
Named provisions
Related changes
Get daily alerts for USPTO Patent Applications - Therapeutics (A61P)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Therapeutics (A61P) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.